Alpha Paradigm Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$474K	Buy	10,241 +3,496	+52%	+$162K	0.2%	176
2022 Q3	$279K	Buy	+6,745	New	+$279K	0.12%	250
2022 Q2	–	Sell	-6,806	Closed	-$494K	–	612
2022 Q1	$494K	Buy	6,806 +5,464	+407%	+$397K	0.19%	176
2021 Q4	$113K	Buy	+1,342	New	+$113K	0.05%	413